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It has been postulated that paternal gonadal exposure would increase the sex ratio by inducing X-chromosomal dominant lethals but
that maternal gonadal exposure would decrease the sex ratio by inducing recessive sex-linked lethals. We therefore evaluated the
sex ratio (male-to-female ratio) of children born to survivors of childhood cancers in Denmark. Children with cancer were identified
from the Danish Cancer Registry from 1943 to 1996 and their offspring from the Central Population Registry. Radiation treatments
were determined from records within the Cancer Registry and gonadal radiation exposures were estimated based on the cancer
being treated and the likely proximity of the radiation fields to the gonads. Overall, 1100 survivors of childhood cancer became the
parents of 2130 children. The sex ratio for male (0.99) and female (1.00) cancer survivors was similar and did not differ significantly
from the Danish population (1.06). Radiotherapy did not influence the sex ratio of the children of either male or female survivors, and
there was no evidence for dose-related changes over categories of estimated dose to parental gonads. We saw no consistent
association between the sex ratio and the interval between cancer diagnosis of the parent and birth of the child. This nationwide
study provides no support for the hypothesis that radiation exposure to the gonads results in an inherited genetic effect that would
be manifested by a change in the sex ratio of children born after exposure. It may be, however, that sex ratio alterations are not a
good or even a valid indicator of possible genetic effects in humans.
British Journal of Cancer (2003) 88, 382–387. doi:10.1038/sj.bjc.6600748 www.bjcancer.com
& 2003 Cancer Research UK
Keywords: childhood cancer; sex ratio in offspring; population-based cohort study; epidemiology
                                                    
In 1958, a possible alteration in the ratio of male-to-female births
(the sex ratio) was suggested following parental exposure among
survivors of the atomic bombings of Hiroshima and Nagasaki
(Schull and Neel, 1958). The changes in the sex ratio were in the
direction expected if exposure had resulted in the induction of sex-
linked lethal mutations (Neel, 1963). However, an extended study
published in 1966 that increased the sample size by about 70% to
47624 children of parents exposed to atomic radiation failed to
confirm the earlier finding of a change in the sex ratio of the
offspring of the survivors (Schull et al, 1966). Recognition of the
sex chromosome aneuploidy and the Lyonisation effect has
brought into question the utility of the sex ratio as an indicator
of an inherited radiation-induced genetic effect (Neel et al, 1990;
Neel and Schull, 1991). Nonetheless, there continues to be an
interest in evaluating sex ratio following paternal preconceptional
radiation with inconsistent results–the most recent studies
evaluated more than 16000 offspring of men employed at the
Sellafield nuclear installation in Cumbria (Dickinson et al, 1996)
and over 46000 children born to nuclear industry workers in the
UK (Maconochie et al, 2001).
Studies of the offspring of survivors of childhood and adolescent
cancer offer a unique opportunity to evaluate whether preconcep-
tion radiation can alter the sex ratio. Gonadal doses are of
sufficient levels (typical between 0.01 and 2Gy from scatter
radiation) (Boice et al, 2002, unpublished data) and sample sizes
are sufficiently large to have adequate power (Boice et al, 2000).
Furthermore, the results of such high dose studies can be
contrasted with the lower dose studies of occupationally or
environmentally exposed populations (Dickinson et al, 1996;
Maconochie et al, 2001; UNSCEAR, 1993, 2001).
Previous studies on the sex ratio among offspring of survivors of
childhood cancer have provided little evidence for an alteration
following curative therapies (Hawkins, 1991; Byrne et al, 1998). In
a large and comprehensive nationwide population-based cohort
study using the unique population and health registries within
Denmark, we have investigated whether radiotherapy received by
childhood cancer patients affected the sex ratio of their offspring.
MATERIAL AND METHODS
Identification of childhood cancer survivors
Files of the national Danish Cancer Registry were used to identify
all patients diagnosed with cancer before 20 years of age from 1943
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yto 1996. Included for study were those patients alive on or born
after 1 April 1968, when the national Central Population Register
(CPR) was established (and when all citizens were assigned a
personal identification number). Throughout this paper, we will
refer to these patients as childhood cancer survivors. The personal
identification number, which is unique to every Danish citizen,
incorporates date of birth and sex, and permits accurate linkage of
information between registers. The Cancer Registry provided
information on date of diagnosis, type of malignant neoplasm and
information on radiotherapy on an yes/no level. Details on the
registration and coding practices have been described previously
(Danish National Board of Health, 1999). The 1100 cancer
survivors (index patients) who met the inclusion criteria were
grouped in one of the 12 main diagnostic tumour groups according
to the international classification scheme for childhood cancer
(Birch and Marsden, 1987).
Identification of offspring
Offspring of index patients were identified through the CPR, which
maintains a link between the personal identification numbers of
parents and children. A total of 2130 children born in Denmark
between 1 April 1968 and 1 January 2000 were included in the
evaluation of the sex ratio.
Radiation exposure
Information on radiotherapy (on an yes/no level) was available
from notification forms in the Danish Cancer Registry. Notifica-
tions are forwarded to the Danish Cancer Registry from hospital
departments when a case of cancer is diagnosed and when changes
in the initial diagnosis and treatment (within 4 first months after
diagnosis) occur (Danish National Board of Health, 1999). The
likelihood of scattered radiation to the gonads was estimated based
on the type of neoplasm being treated, knowledge of treatment
procedures for specific tumours during the study period and
assumptions of the gonadal proximity to the radiation field. Five
categories of estimated radiation dose to the gonads were
developed: low, low or medium, medium, medium or high and
high dose. For some tumours, such as brain tumours, the scatter
dose to gonads is very low whereas for other tumours, such as of
gonadal origin, the radiation dose is high. The categories ‘low or
medium’ and ‘medium or high’ were developed to mean that the
true gonadal exposure could be in either of these two categories
but sufficient details were not available to make the correct
assignment.
Statistical methods
Results are presented in terms of the offspring sex ratio – the ratio
of the number of male births to the number of female births
(M/F ratio) among survivors. To adjust for factors other than
radiotherapy that might influence the sex ratio among offspring
of childhood cancer survivors, the M/F ratio of non-irradiated
parents was used as the referent category.
We conducted a log-linear analysis of the M/F ratio; that is,
a logistic regression analysis with male sex of the child as
the outcome variable. Separate analyses were performed for the
offspring of male and female cancer survivors. The effect of
radiation exposure was evaluated considering different proxy
measures of exposure. The main variable was the information on
radiotherapy (yes/no) obtained from the Danish Cancer Registry
computerised records. Radiotherapy was considered as a single
variable as well as in interaction models with other variables one
at a time; that is, the 12 main diagnostic tumour groups, five
categories of estimated gonadal radiation dose as described
above, and the interval between cancer diagnosis of the parent
and the birth of the offspring.
In the analyses, the following potential confounders were
considered: age of mother, age of father and birth order of
the child. Since adjustment for these variables did not affect the
results, the unadjusted results are presented. Statistical tests
are based on the likelihood ratio test statistic and confidence
limits are based on Wald’s test statistic on the log scale.
The trend test for categories of estimated gonadal radiation dose
was performed in a model assuming a linear effect of the group
number 1 (low) to 5 (high) on the log M/F ratio. The test of
interaction between radiotherapy and interval between cancer
diagnosis of the parent and birth of the offspring was performed
modelling the effect of the exact interval on the M/F ratio as linear
on the log scale, and testing whether significantly different trends
occurred among the offspring of irradiated and non-irradiated
parents. The number of male and female births in the general
Danish population was available from published statistics (Statis-
tics Denmark, 1997).
RESULTS
The sex ratio among 2130 offspring of childhood cancer survivors
(1056 offspring of 550 male survivors and 1074 offspring of 550
female survivors) is presented in Table 1. The sex ratios of the
children born to both male (M/F ratio¼0.99; 95% CI: 0.88–1.16)
and female (M/F ratio¼1.00; 95% CI: 0.89–1.13) survivors were
Table 1 M/F ratios among 2130 offspring
a of 1100 childhood cancer survivors, by sex of the survivor and exposure to radiotherapy
b compared to the
general Danish population
Study
populations
treatment
No. of
offspring
No. of
male offspring
M/F offspring
ratio (95% CI)
M/F offspring ratio among
irradiated parents divided by
M/F offspring ratio among
non-irradiated parents (95% CI)
Danish population
c 1986351 1020708 1.06
Childhood cancer survivors
Males (n=550) 1056 525 0.99 (0.88–1.16)
Non-irradiated 665 334 1.01 (0.87–1.17)
Irradiated 391 191 0.96 (0.78–1.16) 0.95 (0.74–1.22)
Females (n=550) 1074 538 1.00 (0.89–1.13)
Non-irradiated 720 355 0.97 (0.84–1.13)
Irradiated 354 183 1.07 (0.87–1.32) 1.10 (0.85–1.42)
M/F=male-to-female ratio. CI=confidence interval.
aChildren born between 1 April 1968 and 1 January 2000.
bInformation from the Danish Cancer Registry.
cChildren born
between 1968 and 1998.
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population. Radiotherapy did not affect the M/F ratio of the
children of either male or female cancer survivors.
Table 2 presents the M/F ratios among the offspring of
childhood cancer survivors, by sex of survivor, main diagnostic
tumour group and exposure to radiotherapy. Diagnostic groups
are listed according to increasing estimated radiation dose to the
gonads. No systematic pattern was observed; that is, no pattern
was seen in the M/F ratio among offspring of irradiated parents
relative to the M/F ratio among non-irradiated parents in
diagnostic tumour groups with presumably high gonadal doses
(e.g. lymphomas or Wilms tumour) compared to groups with low
gonadal doses (e.g. CNS tumours or retinoblastomas) (Figure 1).
If the postulated genetic effect of radiation occurred, one would
had expected the M/F offspring ratio among irradiated parents
divided by the M/F offspring ratio among non-irradiated
parents to increase for male survivors and decrease for female
survivors. There was no significant interaction between radiation
and main diagnostic tumour group for either male (P¼0.99) or
female survivors (P¼0.69). M/F ratios, by survivor sex and
estimated gonadal radiation dose, are given in Table 3. No significant
trend according to these categories was observed (male survivors:
P¼0.48; female survivors: P¼0.51).
Table 4 shows M/F ratios, comparing the ratio of the children of
irradiated parents with the children of non-irradiated parents, by
interval between cancer diagnosis of the parent and birth of the
child. No significant trends were found (male survivors: P¼0.11;
female survivors: P¼0.18). The only significant finding was a low
relative M/F ratio for the offspring of female cancer survivors born
25 or more years after radiation treatment (0.31; 95% CI 0.14–
0.69). The ratios of the M/F ratio among offspring of irradiated to
non-irradiated male (4.00) and female (0.85) childhood cancer
survivors born within 5 years of treatment were in the direction of
the postulated genetic effect, but neither was significant.
Information on chemotherapy was judged to be too incomplete
in this study to investigate possible effects on the M/F ratio.
However, data from a similar patient group included in a Nordic
case–control study on second malignant neoplasms after child-
hood cancer was made available to us (Garwicz et al, 2000). Based
on a review of the records of 678 childhood cancer patients with
Table 2 M/F ratios among offspring of childhood cancer survivors, by sex of survivor, main diagnostic tumour group (listed according to increasing
estimated radiation dose to the gonads) and exposure to radiotherapy
M/F offspring ratio among
No. of offspring M/F offspring ratios irradiated parents divided
by M/F offspring ratio
Main diagnostic tumour
group (group no.)
a
Sex of
survivor (no.) Total
Irradiated
parents
Irradiated
parents
Non-irradiated
parents
among non-irradiated
parents (95% CI)
Central nervous system neoplasms (III) M (102) 215 48 0.85 0.86 0.99 (0.52–1.88)
F (122) 243 60 1.22 0.95 1.29 (0.72–2.32)
Sympathetic nervous system tumours (IV) M (9) 16 4 1.00 1.40 0.71 (0.07–6.92)
F (14) 24 18 1.00 2.00 0.50 (0.07–3.45)
Retinoblastoma (V) M (26) 41 6 0.50 1.06 0.47 (0.08–2.92)
F (37) 80 14 0.56 1.13 0.49 (0.15–1.63)
Malignant bone tumours (VIII) M (27) 68 25 0.56 0.72 0.78 (0.28–2.16)
F (22) 39 9 1.25 1.00 1.25 (0.28–5.59)
Hepatic tumours (VII) M (1) 3 0 F 2.00 F (F)
F (1) 1 0 F 0.00 F (F)
Leukaemias (I) M (31) 53 9 2.00 1.32 1.52 (0.34–6.87)
F (45) 78 26 1.36 0.93 1.47 (0.57–3.81)
Carcinomas and other malignant epithelial
neoplasms (XI)
M (66) 125 25 1.50 1.22 1.22 (0.50–2.99)
F (135) 292 55 1.04 0.94 1.10 (0.61–1.98)
Soft-tissue sarcomas (IX) M (57) 118 28 0.75 1.00 0.75 (0.32–1.76)
F (46) 85 24 0.85 1.18 0.71 (0.28–1.85)
Other and unspecified malignant
neoplasms (XII)
M (9) 17 3 0.50 0.75 0.67 (0.05–9.19)
F (7) 16 5 4.00 0.57 7.00 (0.57–86.33)
Lymphomas (II) M (110) 205 143 0.96 1.07 0.90 (0.50–1.63)
F (81) 139 101 1.06 1.24 0.86 (0.41–1.82)
Wilms and other renal tumours (VI) M (27) 47 39 1.05 0.60 1.75 (0.37–8.37)
F (19) 36 29 0.93 0.40 2.33 (0.39–14.04)
Germ-cell, trophoblastic and other gonadal
neoplasms (X)
M (85) 148 61 1.10 1.12 0.98 (0.51–1.89)
F (21) 41 13 1.17 0.75 1.56 (0.41–5.84)
M/F=male-to-female ratio. CI=confidence interval.
aGroup number according to the childhood cancer classification (Birch and Marsden, 1987).
Childhood cancer and sex ratio in offspring
JF Winther et al
384
British Journal of Cancer (2003) 88(3), 382–387 & 2003 Cancer Research UK
E
p
i
d
e
m
i
o
l
o
g
yvarious diagnoses, chemotherapy was used to treat all 75 patients
diagnosed with leukaemia (I), 78% of patients with Wilms tumour
(VI) but only 2% of patients with carcinomas and other malignant
epithelial neoplasms (XI) (personal communication with Anderson
H). The M/F ratio among childhood cancer survivors in our study
with leukaemia (1.41 for male and 1.10 for female survivors) and
with Wilms tumour (0.96 for male and 0.80 for female survivors)
did not differ from the ratio among survivors with carcinomas
(1.27 for male and 0.96 for female survivors) (figures not shown in
tables).
DISCUSSION
Radiation treatment of childhood cancer patients did not alter the
sex ratio of their children. No changes in sex ratio were seen for
the children of either male or female cancer survivors or over
categories of estimated gonadal radiation dose. Experimental
evidence (Russell, 1965) suggests that in female mice the yield in
mutations, following an exposure experience, may diminish with
time either as a consequence of the repair of certain mutations
(for a discussion, see Moustacchi, 2000), of cell selection, or both.
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Figure 1 M/F ratio among offspring of irradiated parents relative to the ratio among non-irradiated parents, by the male (#) and female (~) survivor sex
and main diagnostic tumour group (listed according to increasing estimated gonadal radiation dose; groups with few observations are not included in the
ranking but plotted separately). If the postulated genetic effect of radiation occurred, one would have expected the ratios of the M/F ratio among offspring of
irradiated to non-irradiated parents to increase for male survivors and decrease for female survivors.
Table 3 M/F ratios among offspring of childhood cancer survivors, by sex of survivor and estimated gonadal radiation exposure
Survivor sex (no.)
Radiation
exposure
a No. of offspring
M/F offspring
ratio
M/F offspring ratio among irradiated
parents divided by M/F offspring ratio
among non-irradiated parents (95% CI)
Males (550) No 665 1.01 1.00 (ref.)
b F
Yes 391 0.96 0.95 (0.74–1.22)
Low 79 0.88 0.87 (0.55–1.39)
Low or medium 36 0.80 0.79 (0.40–1.56)
Medium 67 0.91 0.91 (0.55–1.50)
Medium or high 144 0.97 0.96 (0.67–1.38)
High 61 1.10 1.09 (0.65–1.85)
Unknown 4 3.00 2.97 (0.31–28.7)
Females (550) No 720 0.97 1.00 (ref.)
b F
Yes 354 1.07 1.10 (0.85–1.42)
Low 143 1.07 1.10 (0.77–1.58)
Low or medium 39 1.05 1.08 (0.57–2.06)
Medium 26 1.00 1.03 (0.47–2.25)
Medium or high 101 1.06 1.09 (0.72–1.66)
High 44 1.10 1.13 (0.61–2.07)
Unknown 1 FF F
M/F=male-to-female ratio. CI=confidence interval.
aEstimate based on information on cancer diagnosis of survivors from the Danish Cancer Registry files with assumptions made
with regard to gonadal proximity to likely radiation field.
bReferent category.
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mutations within a few hours or days of exposure, there is evidence
that genetic changes may continue to occur for much longer
periods of time. It is conceivable, therefore, that the number of
sex-linked lethal mutations potentially recoverable could diminish
with time and our failure to find a radiation-related effect on the
sex ratio reflect this reduction. To examine this thesis, we analysed
the changes in the sex ratio over intervals of time between
treatment and birth of the children.
The only suggestion of a possible association occurred among
children born within 5 years of treatment for both male and
female cancer survivors. However, neither of the relative M/F
offspring ratios, comparing offspring of irradiated to non-
irradiated parents, was close to significant and there was no
heterogeneity in the six interval categories except for a reduced
relative M/F ratio among children born 25 years or more after
maternal treatment. As we would have expected the reduction of
the relative M/F ratio among children of irradiated mothers to
either diminish with time or at least to stay below 1.0, this
significant finding was believed to be a chance finding because of
multiple comparisons.
Thus, we find no support for the possibility that high-dose
radiation exposures might be associated with an inherited genetic
change as indicated by a change in the sex ratio. Reasons for our
negative findings might be that the radiation exposure, though
large, was not sufficient to result in a detectable genetic effect, that
sex ratio is a poor indicator of genetic effects, or that our study had
inherent weaknesses that masked a change in the sex ratio.
The typical radiation dose to the gonads following treatment of
childhood cancers of patients who later had children were by
definition in the non-sterilising range of between 0.01 and 2Gy,
which is similar to the range reported for atomic bomb survivors
and much larger than exposures in studies of occupational or
environmental circumstances. Our study is consistent with the
negative findings in the atomic bomb survivor study (Schull et al,
1966) and in two previous studies of survivors of childhood cancer
(Hawkins, 1991; Byrne et al, 1998). In the most recent and
comprehensive study, Byrne et al evaluated the sex ratio of 2198
offspring born to male and female survivors treated before 1976,
compared with that of 4544 offspring born to controls (1.05 vs 1.00,
respectively, for males, and 1.01 vs 1.05, respectively, for females).
Neither difference reached statistical significance. Furthermore,
no statistically significant differences were observed comparing
survivors treated with potentially mutagenic therapy vs those
without this treatment.
Other studies of possible genetic effects in humans related to
radiation exposure have included groups exposed to ionising
radiation received occupationally; for example, nuclear radiation
workers and X-ray technologists. These workers receive smaller
exposures than the Japanese atomic bomb survivors and childhood
cancer survivors. Direct irradiation of the gonads from cancer
treatments will result in doses of 10Gy or more, while scattered
radiation for many treatments, such as for the Wilms tumour,
could result in testes doses in the order of 0.2–2Gy. Depending on
age, a child treated with cranial radiation receives 0.02–0.2Gy to
the testes (Boice et al, 2000; 2002, unpublished data). Other than
differences in dose, there are differences in dose rate between
workers who are exposed to low dose over many years and atomic
bomb survivors and cancer survivors who are exposed to higher
does at high dose rates at one point in time or repeated over about
6 weeks. Animal studies show that genetic effects are three times
greater when the dose is delivered acutely compared to protracted
(Hawkins, 1991; UNSCEAR, 2001). Our study, including patients
with high gonadal exposures compared to occupational exposures,
does not support previous suggestions of an association of
parental exposure with the sex ratio of the offspring.
Our data are also consistent with the latest follow-up of the
children of the atomic bomb survivors (Neel and Schull, 1991),
which had previously led to a re-interpretation of the value of sex
ratio as an indicator of transmitted genetic effects. During the
middle of the 20th century, sex determination was thought to be
much simpler than is now believed to be the case. X-inactivation
and the many sex chromosome abnormalities are known to
interfere with gene expression and can influence the proper
designation of gender. Such phenomena bring into doubt the
validity of the assumption, in humans, that gonadal exposure in
males would be expected to increase the M/F ratio and gonadal
exposure in females would be expected to decrease the M/F ratio.
These simplistic assumptions of radiation effects on parental germ
cells is subject to such uncertainty that the sex ratio should not be
considered a useful measure of genetic effect. Furthermore, it has
been suggested that natural background factors such as concep-
tions occurring on different days of the menstrual cycle might
be associated with marked variations in the sex ratio (Harlap,
1979). Such natural factors might tend to blur observations on sex
ratio changes caused by other preconceptional exposures being
Table 4 M/F ratios among offspring of childhood cancer survivors by sex of survivor, exposure to radiotherapy and interval between cancer diagnosis of
parent and birth of offspring
M/F offspring ratio among
No. of offspring M/F offspring ratios irradiated parents divided
by M/F offspring ratio
Survivor
sex (no.)
Interval
(year) Total
Irradiated
parents
Irradiated
parents
Non-irradiated
parents
among non-irradiated
parents (95% CI)
Males (550) o5 38 10 4.00 1.00 4.00 (0.72–22.3)
5–9 171 50 0.85 1.09 0.78 (0.41–1.52)
10–14 250 106 1.04 0.97 1.07 (0.67–1.76)
15–19 213 91 0.86 0.88 0.98 (0.57–1.68)
20–24 185 65 1.03 0.76 1.35 (0.74–2.47)
X25 199 69 0.82 1.45 0.56 (0.31–1.01)
Females (550) o5 90 21 0.62 0.73 0.85 (0.31–2.31)
5–9 235 61 1.10 1.07 1.03 (0.57–1.85)
10–14 255 88 1.20 1.06 1.13 (0.67–1.90)
15–19 224 76 1.11 0.66 1.68 (0.96–2.93)
20–24 155 62 1.30 0.82 1.57 (0.82–3.01)
X25 115 46 0.77 2.45 0.31 (0.14–0.69)
M/F=male-to-female ratio. CI=confidence interval.
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might not be a particularly good or valid indicator of heritable
genetic damage.
Our study has a number of strengths. It is population-based,
covering the entire country of Denmark since 1943. Practically all
cancer patients alive in 1968 or born thereafter, and their children
were identified from accurate population registries. The sex of the
child is routinely collected and subject to little uncertainty in
reporting. Thus there is little likelihood that selection bias is
present that could distort our study results.
Our study, however, also has several limitations. The fact of
radiation exposure was taken from notifications in the Danish
Cancer Registry for the 1100 survivors included in the study
cohort. To validate this assessment, it was compared with informa-
tion in the medical records on 189 Danish childhood cancer
patients included in a previous nested case–control study of second
cancers (Garwicz et al, 2000). This procedure revealed a relatively
high validity of the exposure variable; that is, a high sensitivity
(88% of all cases receiving radiotherapy was recorded in the Cancer
Registry) and specificity (99% of those receiving no radiotherapy
was coded as such in the Registry). Although the registry details
seem reliable, misclassification does reduce our ability to detect an
association between radiation and sex ratio. We assumed average
levels of dose to testes or ovaries based on the type of cancer being
treated and the calendar year of treatment. For such cancers as
those of brain or kidney, the categorisation is reasonably accurate
but for others, such as lymphoma or sarcomas, the range of possible
gonadal doses could be broad. Nonetheless, we did not observe any
patterns in the offspring sex ratio that suggested changes because of
these broad categories of gonadal exposure.
Owing to lack of information, we were unable to examine
potential effects on the M/F ratio among offspring of survivors
treated with various chemotherapeutic agents or to adjust the
effect of radiotherapy on the M/F ratio for these agents. However,
no significant dose–response pattern was observed between main
diagnostic tumour groups with expected high proportions of
patients treated with chemotherapy compared to patients seldom
treated with these agents.
Most large-scale studies on parity and parental ages suggest an
effect on the sex ratio of birth order and paternal age, and in some
studies, also of maternal age (summarised in Jacobsen et al, 1999).
In a large Danish study of more than 800000 births, 1980–1993, no
independent effect was observed for maternal age or birth order,
whereas the sex ratio decreased with paternal age (Jacobsen et al,
1999). In our analyses, adjustment for these variables did not affect
the results. It has also been argued that the sex determination is
not a fully random event. An association with the sexes of
previously born children in the family could either be because of in
utero interaction with the sex of the previous child affecting the sex
of the current child (‘Markov association’) or because of a pre-
disposition of individuals or couples to have predominantly
children of a particular sex (‘Lexis association’) (Jacobsen et al,
1999). The large Danish study, however, found no association either
with the sex of the preceding child or the combination of sexes of
previously born children in the family. Therefore, our statistical
analyses were predicated on the supposition that the observations
on the sex of offspring within a family are independent.
In conclusion, survivors of childhood and adolescent cancers
were not found to have alterations in the sex ratio of their children
that could be linked to prior radiation treatments. This may
suggest that the human is relatively immune to this type of
genetic effect, or, more likely, that alteration in the sex ratio
is a poor indicator of genetic effects in humans and should
probably not be considered as such, even when gonadal doses
are high.
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